This website uses cookies to provide necessary functionality and to improve your online experience. By using this website you accept our use of cookies and the Privacy Statement.
Name of study | APIs and strength | Base | Action |
---|---|---|---|
Chemical Stability of Hydrocortisone in Topical Preparation in Proprietary VersaPro Cream Base (potency-over-time only) | Hydrocortisone | VersaPro Cream Base | |
Stability Studies on Naproxen Cream (potency-over-time only) | Naproxen | PLO Gel Mediflo30 | |
Ninety Day Chemical Stability of Compounded Estradiol, Estrone and Estriol Combination and Beyond Use Date (potency-over-time only) | Estradiol, Estriol, Estrone | VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base | |
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs | Metronidazole, Metronidazole, Metronidazole, Theophylline, Theophylline, Theophylline, Levocarnitine, Levocarnitine, Levocarnitine | CapsuBlend-S, CapsuBlend-P, CapsuBlend-H, CapsuBlend-S, CapsuBlend-P, CapsuBlend-H, CapsuBlend-S, CapsuBlend-P, CapsuBlend-H | |
Chemical Stability of Progesterone in Compounded Topical Preparations using PLO Transdermal Cream and HRT Cream Base over a 90-Day Period at Two Controlled Temperatures (potency-over-time only) | Progesterone, Progesterone | PLO Transdermal Cream, HRT Cream Base | |
Chemical Stability of Compounded Spironolactone Suspension in Proprietary Oral Mix™ Over a 90-day Period at Two Controlled Temperatures in Different Storage Containers (potency-over-time only) | Spironolactone | Oral Mix | |
Stability of Extemporaneously Compounded Clobazam 1mg/mL Suspension | Clobazam | Oral Mix | |
Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes | Clonidine Hydrochloride, Clonidine Hydrochloride | Oral Mix, Oral Mix, SF | |
Stability of Extemporaneously Compounded Dexamethasone in Glass and Plastic Bottles and Plastic Syringes | Dexamethasone, Dexamethasone | Oral Mix, Oral Mix, SF | |
Standard of Practice, Professional Judgement, and Scientific Evidence to Establish and Extend a Beyond-use Date | N/A | N/A | |
Evaluation of the Inversina Manual Mixer - Powders and Liquids | N/A | N/A | |
In Vitro Evaluation of the Percutaneous Absorption of Progesterone in Medisca VersaPro Cream Base | Progesterone | VersaPro Cream Base | |
Stability of Extemporaneously Compounded Pyridoxine in Glass and Plastic Bottles and Plastic Syringes | Pyridoxine Hydrochloride, Pyridoxine Hydrochloride | Oral Mix, Oral Mix, SF | |
Bedside Manner: Not Just For Doctors Anymore | N/A | N/A | |
In Vitro Evaluation of the Percutaneous Absorption of Diclofenac Sodium in Medisca VersaPro Gel Base | Diclofenac Sodium | VersaPro Gel Base | |
Stability of Extemporaneously Compounded Levetiracetam in Glass and Plastic Bottles and Plastic Syringes | Levetiracetam, Levetiracetam | Oral Mix, Oral Mix, SF | |
Comparison of the Percutaneous Absorption of Compounded Medications in Liposomal vs Non-Liposomal Vehicles | Diclofenac Sodium, Diclofenac Sodium | Transdermal Pain Base, VersaPro Cream Base | |
In Vitro Evaluation of the Percutaneous Absorption of Diclofenac Sodium in Transdermal Pain Base | Diclofenac Sodium | Transdermal Pain Base | |
Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes | Naproxen, Naproxen | Oral Mix, Oral Mix, SF | |
Quality Control Analytical Methods. Physical Quantitative Verification of Nonsterile Compounding Preparations: Individualized Dosage Units | N/A | N/A |
Rows per page